This inventor holds 2 USPTO granted patents. Top assignees: Naviga LLC, Other. Active years: 2016-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2018
Title: Rebecca Caffrey: Innovator in Bioavailable Testosterone Measurement
Introduction
Rebecca Caffrey is a notable inventor based in Chesterfield, VA (US). She has made significant contributions to the field of biochemistry, particularly in the measurement of bioavailable testosterone. With a total of 2 patents, her work has implications for both clinical and research applications.
Latest Patents
Caffrey's latest patents focus on methods for determining the level of bioactive testosterone in biological samples. One method involves utilizing the aromatase enzyme to convert free, bioavailable testosterone into estradiol. The amount of estradiol is measured before and after the addition of the enzyme, allowing for the determination of bioactive testosterone levels in the sample. Another aspect of her work involves using a competitor of testosterone binding to sex hormone-binding globulin (SHBG) to displace testosterone that is bound to SHBG. Measurements of total testosterone in the sample are taken before and after the addition of the competitor, with the delta reflecting the amount of testosterone that was previously bound to SHBG.
Career Highlights
Throughout her career, Rebecca Caffrey has worked with various companies, including Naviga LLC. Her innovative approaches to measuring testosterone levels have garnered attention in the scientific community.
Collaborations
Caffrey has collaborated with professionals in her field, including her coworker Daniel M Hoefner. These collaborations have likely contributed to the advancement of her research and the successful development of her patents.
Conclusion
Rebecca Caffrey is a pioneering inventor whose work in the measurement of bioavailable testosterone has the potential to impact both clinical practices and research methodologies. Her contributions to the field are noteworthy and reflect her dedication to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile